TeamDrive
RUS

Russias drugs exports in January November 2017 amounted to 19 billion rubles

12 January 2018

GMP News

In the first 11 months of 2017, the exports of medicinal products from Russia (excluding the shipments to EAEU) reached 19.0 billion rubles (including the customs duties). This means that, when calculated in the Russian currency, the increase over the same period of 2016 was only 0.4%. However, the mere fact of positive dynamics is quite encouraging, as the results for January-October were much gloomier (at that time, the long-term growth rate was -2.2%).

The active efforts of exporters reversed the situation in November 2017. For that month, the total exports of medicinal products from Russia reached 2.3 billion rubles, an increase was 23% in ruble terms. Although this was not a record-breaking result, it is still quite outstanding, since better dynamics have been demonstrated by exporters only in January 2017, when the shipments increased by 58%.

In physical terms, the exports in November 2017 amounted to 70.8 million packages, a 22% increase year over year. Moreover, throughout the year, the general dynamics in physical terms can be described as rather successful. Despite occasional downturns reported, for example, for February when the exports in terms of shipped packages fell by 38%, the overall results for the first 11 months of 2017 have been markedly positive (+7.3%). Since the beginning of 2017, the total exports of medicinal products from Russia reached 536.4 million packages.


Previous publication Next publication

Media Center

  • 22 June 2018

    Drug shortages again on the rise after 5 years of improvements, FDA says

    After 5 years of declines in the number of new drug shortages in the U.S., they jumped to 39 last year from 26 in the two preceding years. And while that is a far cry from the peak of more than 250 registered in 2011, the FDA acknowledges that many of the current shortages have been for critical drug products and “are having a tangible impact on patients.”

  • 22 June 2018

    Pfizers 'Living With Cancer' wowed Cannes attendees, if not the pharma jury

    A Pfizer documentary film about five patients living with cancer may have inspired more fanfare at Cannes Lions Health than it did in the eight months since its launch. The “This is Living With Cancer” film and its associated campaign was shortlisted for a pharma award at the annual ad festival and was heaped with praise after Pfizer presented it in an open session.

  • 21 June 2018

    EvaluatePharma World Preview 2018, Outlook to 2024

    EvaluatePharma World Preview 2018, Outlook to 2024

    And according to EvaluatePharma’s World Preview 2018, we are looking at an industry set to experience sales accelerating from the sluggish levels following the financial crisis, to annual compound growth of over 6% between now and 2024. 

  • 21 June 2018

    Russian equipment for storage of thermolabile drugs was delivered to China

    POZIS JSC, an affiliate of Techmash concern of Rostec Corporation, for the first time delivered Russian medical equipment to Hong Kong. Under the contract, the customer received HF-140 POZIS, pharmaceutical refrigerators designed for storage of thermolabile drugs, and RBC-2, new generation compact bactericidal recirculators for air disinfection.

Read more